FDA Approves Standalone Use of Johnson & Johnson’s Spravato for Depression
The FDA has expanded the approval of Johnson & Johnson's nasal spray, Spravato, for standalone use in treating major depressive disorder.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
The FDA has expanded the approval of Johnson & Johnson's nasal spray, Spravato, for standalone use in treating major depressive disorder.
Read More
In this study, low-dose ketamine led to significant improvements in mood and cognition within just a few hours of treatment.
Read More
A Veteran's Affairs official is hopeful that RFK Jr's psychedelics stance could bring reform and potential FDA approved treatments.
Read More
Starting January 1st, Wisconsin Medicaid will cover IV ketamine therapy for major depressive disorder, including cases with suicidality.
Read More
The death of “Friends” star Matthew Perry has put ketamine under the spotlight. This CNN ketamine flashdoc dives into this emerging therapy.
Read More
In a promising new study, ketamine has shown some exciting results in helping treat patient's Parkinson's symptoms.
Read More
Another state to add to the list? A task force in Minnesota has advocated for legalizing psychedelic mushrooms.
Read More
Have you wondered which psychedelic treatment was right for you? We have a breakdown of everything from psilocybin to ketamine.
Read More
Ketamine zebrafish study? Yes! Research on ketamine’s effect on zebrafish sheds light on its potential as a faster-acting antidepressant.
Read More
A Church or a Dispensary? California's largest psychedelic church is being forced to to shut down its Oakland location.
Read More